To the tune of $550,000, the Bala-Cynwyd-based Alex’s Lemonade Stand Foundation has funded the release of genomic data on 270 cancer tumors.
The data set spans 25 unique pediatric cancer types, writes Roberto Torres at technical.ly.
The data release is done in partnership with the National Cancer Institute–backed Pediatric Preclinical Testing Consortium (PPTC).
The data will let researchers and labs skip lengthy preclinical research work and deploy more precise clinical trials in the development of new treatments against pediatric cancer.
This is momentous,” said Dr. John Maris, a pediatric oncologist at Children’s Hospital of Philadelphia, who sits on ALSF’s Scientific Advisory Board and is a participating member in the Consortium. “The deep genetic profiling enabled as a result of ALSF’s funding contribution to the PPTC overcomes some major problems we have when treating childhood cancer. The data allows us to treat a genetic target, rather than the disease name.”
To read the full story, click here.